Advanced Biomed Statistics
Total Valuation
Advanced Biomed has a market cap or net worth of $82.45 million. The enterprise value is $83.51 million.
| Market Cap | 82.45M |
| Enterprise Value | 83.51M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Advanced Biomed has 21.64 million shares outstanding. The number of shares has increased by 0.11% in one year.
| Current Share Class | 21.64M |
| Shares Outstanding | 21.64M |
| Shares Change (YoY) | +0.11% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 82.12% |
| Owned by Institutions (%) | n/a |
| Float | 3.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 73.14 |
| P/TBV Ratio | 84.01 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.95, with a Debt / Equity ratio of 1.21.
| Current Ratio | 0.95 |
| Quick Ratio | 0.88 |
| Debt / Equity | 1.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -239.77% and return on invested capital (ROIC) is -96.29%.
| Return on Equity (ROE) | -239.77% |
| Return on Assets (ROA) | -36.72% |
| Return on Invested Capital (ROIC) | -96.29% |
| Return on Capital Employed (ROCE) | -225.13% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$56,914 |
| Employee Count | 40 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 62.44 |
| Average Volume (20 Days) | 126,827 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -2.62M |
| Pretax Income | -4.75M |
| Net Income | -2.28M |
| EBITDA | -2.34M |
| EBIT | -2.62M |
| Earnings Per Share (EPS) | -$0.11 |
Balance Sheet
The company has $2.65 million in cash and $1.32 million in debt, giving a net cash position of $1.32 million or $0.06 per share.
| Cash & Cash Equivalents | 2.65M |
| Total Debt | 1.32M |
| Net Cash | 1.32M |
| Net Cash Per Share | $0.06 |
| Equity (Book Value) | 1.09M |
| Book Value Per Share | 0.05 |
| Working Capital | -176,636 |
Cash Flow
In the last 12 months, operating cash flow was -$1.54 million and capital expenditures -$94,088, giving a free cash flow of -$1.63 million.
| Operating Cash Flow | -1.54M |
| Capital Expenditures | -94,088 |
| Free Cash Flow | -1.63M |
| FCF Per Share | -$0.08 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Advanced Biomed does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.11% |
| Shareholder Yield | -0.11% |
| Earnings Yield | -2.68% |
| FCF Yield | -1.92% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |